Bullous hemorrhagic dermatosis due to enoxaparin use in a bullous pemphigoid patient

Ji-Su SHIM; Soo-Jie CHUNG; Byung-Keun KIM; Sae-Hoon KIM; Kyu-Sang LEE; Yeonyee-E YOON; Yoon-Seok CHANG.
Asia Pacific Allergy ; (4): 97-101, 2017.
Artículo en Inglés | WPRIM | ID: wpr-750096

Documentos relacionados

  1. Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients.
  2. Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery.
  3. Glycan Mapping of Low-Molecular-Weight Heparin Using Mass Spectral Correction Based on Chromatography Fitting with "Glycomapping" Software.
  4. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
  5. [Hemorrhagic bullous dermatosis (HBD): A rare side-effect of heparins].
  6. Rituximab in Subepidermal Blistering Diseases.
  7. Bullous Pemphigoid and Other Pemphigoid Dermatoses.
  8. Potential contribution of anti-p200 autoantibodies to mucosal lesions in anti-p200 pemphigoid.
  9. Autoimmune bullous dermatoses.
  10. [Mucosal anomalies in autoimmune bullous diseases].